Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("MITOLACTOL")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 61

  • Page / 3
Export

Selection :

  • and

FORMS AND RESULTS OF MITOLACTOL THERAPYHINDY I; SZANTO J; BODROGI I et al.1980; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1980; VOL. 37; SUPPL. 1; PP. 115-117; BIBL. 13 REF.Article

PHASE II STUDY OF DIBROMODULCITOL (NSC-104800)ANDREWS NC; WEISS AJ; WILSON W et al.1974; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 653-660; BIBL. 10REF.Article

PHASE II STUDY OF DIBROMODULCITOL IN COLORECTAL, KIDNEY, AND OTHER CARCINOMASMISCHLER NE; TORMEY DC; KLOTZ J et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 4; PP. 407-410; BIBL. 11 REF.Article

COMPLEX EVALUATION OF THE EFFECT OF SOME CYTOSTATIC HEXITOL DERIVATIVESHOLCZINGER L; SOMFAI RELLE S; INSTITORIS E et al.1980; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1980; VOL. 37; SUPPL. 1; PP. 104-108; BIBL. 14 REF.Article

BONE CHANGES IN YOUNG MICE WITH IMPAIRED LYMPHOID SYSTEMBEREK L; BANOS S; SZERI I et al.1974; ACTA MICROBIOL. ACAD. SCI. HUNGAR.; HONGR.; DA. 1974; VOL. 22; NO 1; PP. 1-8; BIBL. 15REF.Article

DIBROMODULCITOL IN THE TREATMENT OF BREAST CANCER = LE DIBROMODULCITOL DANS LE CANCER DU SEINFALKSON G; PRETORIUS L; FALKSON HC et al.1982; CANCER TREATMENT REVIEWS; ISSN 0305-7372; USA; DA. 1982; VOL. 9; NO 4; PP. 261-266; BIBL. 28 REF.; FIGArticle

DIBROMODULCITOL IN THE TREATMENT OF METASTATIC HEMANGIOPERICYTOMACONROY JF; RODA PI; SRIPRAYOON PRASASVINICHAI et al.1982; AMERICAN JOURNAL OF CLINICAL ONCOLOGY; ISSN 512273; USA; DA. 1982; VOL. 5; NO 4; PP. 453-456; BIBL. 9 REF.Article

METABOLISM AND PHARMACOKINETICS OF DIBROMODULCITOL (DBD, NSC-104800) IN MAN. II: PHARMACOKINETICS OF DBD = METABOLISME ET PHARMACOCINETIQUE DU DIBROMODULCITOL (DBD, NSC-104800) CHEZ L'HOMME. II: PHARMACOCINETIQUE DU DBDHORVATH IP; CSETENYI J; HINDY I et al.1982; EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 11; PP. 1211-1219; ABS. ENG; BIBL. 10 REF.; GRAPHArticle

PILOT STUDIES OF VARIOUS COMBINATIONS OF DIBROMODULCITOL, VP-16, AND AMSAEAGAN RT.1982; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1982; VOL. 39; NO 5; PP. 295-297; BIBL. 5 REF.Article

THERAPEUTISCHE EFFEKTIVITAET VON CARMINOMYCIN (CRM) IN DER KOMBINATION MIT DIBROMODULCITOL (DBD) IM VERGLEICH ZUR KOMBINATION VINCRISTIN, CYCLOPHOSPHAMID METHOTREXAT, 5-FLUOROURACIL (VCMF) AN VERSCHIEDENEN TUMORMODELLEN = EFFICACITE THERAPEUTIQUE DE LA CARMINOMYCINE (CRM) EN ASSOCIATION AVEC LE DIBROMODULCITOL (DBD), PAR COMPARAISON AVEC UNE ASSOCIATION VINCRISTINE, CYCLOPHOSPHAMIDE+METHOTREXATE+FLUOROURACILE (VCMF) DANS QUELQUES SYSTEMES TUMORAUXNOWAK C; ARNOLD W; HENNEBERGER G et al.1980; ARCH. GESCHWULSTFORSCH.; ISSN 0003-911X; DDR; DA. 1980; VOL. 50; NO 8; PP. 747-757; ABS. ENG; BIBL. 43 REF.Article

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix : A Gynecologic Oncology Group studyOMURA, G. A; BLESSING, J. A; VACCARELLO, L et al.Journal of clinical oncology. 1997, Vol 15, Num 1, pp 165-171, issn 0732-183XArticle

Induction chemotherapy of dibromodulcitol, Adriamycin®, vincristine, tamoxifen, and halotestin® with methotrexate in metastatic breast cancer : An Eastern Cooperative Oncology Group Study (E1181)CHANG, A. Y; PUTT, M; PANDYA, K. J et al.American journal of clinical oncology. 1998, Vol 21, Num 1, pp 99-104, issn 0277-3732Article

DIBROMODULCITOL AND ADRIAMYCIN +OU- TAMOXIFEN IN ADVANCED BREAST CANCERTORMEY DC; FALKSON G; CROWLEY J et al.1982; AM. J. CLIN. ONCOL.; ISSN 512273; USA; DA. 1982; VOL. 5; NO 1; PP. 33-39; BIBL. 9 REF.Article

EVALUATION OF AN INTERMITTENT SCHEDULE OF MITOLACTOL IN ADVANCED NON-SMALL CELL LUNG CANCEREAGAN RT; FRYTAK S; NICHOLS WC et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1099-1101; BIBL. 9 REF.Article

PHASE II EVALUATION OF DIBROMODULCITOL, ICRF-159, AND MAYTANSINE FOR SARCOMASBORDEN EC; ASH A; ENTERLINE HT et al.1982; AMERICAN JOURNAL OF CLINICAL ONCOLOGY; ISSN 512273; USA; DA. 1982; VOL. 5; NO 4; PP. 417-420; BIBL. 14 REF.Article

POSITIVE PHASE II TRIAL OF DIBROMODULCITOL IN PATIENTS WITH METASTATIC MELANOMA REFRACTORY TO DTIC AND A NITROSOUREABELLET RE; CATALANO RB; MASTRANGELO MJ et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 12; PP. 2095-2099; BIBL. 18 REF.Article

PHASE II TRIAL OF MITOLACTOL IN PATIENTS WITH METASTATIC MELANOMAMEDINA W; KIRKWOOD JM.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 195-196; BIBL. 6 REF.Article

ADRIAMYCIN PLUS VINCRISTINE ALONE OR WITH DIBROMODULCITOL OR ICRF-159 IN METASTATIC BREAST CANCERCUMMINGS FJ; GELMAN R; TORMEY DC et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 3; PP. 253-260; BIBL. 11 REF.Article

A PILOT STUDY OF MITOMYCIN-C AND TAMOXIFEN (MT) VERSUS DIBROMODULCITOL, ADRIAMYCIN, AND TAMOXIGEN (DAT)YUANG CHI CHANG; FALKSON G; TORMEY DC et al.1982; AMERICAN JOURNAL OF CLINICAL ONCOLOGY; ISSN 512273; USA; DA. 1982; VOL. 5; NO 5; PP. 521-525; BIBL. 8 REF.Article

CHROMOSOMAL ANALYSIS ON YOSHIDA TUMOR CELLS SENSITIVE AND RESISTANT TO DIBROMODULCITOLGATI E.1979; NEOPLASMA; CSK; DA. 1979; VOL. 26; NO 1; PP. 79-83; BIBL. 8 REF.Article

METABOLISM AND PHARMACOKINETICS OF DIBROMODULCITOL (DBD, NSC-104800) IN MAN. I: METABOLITES OF DBDHORVATH JP; CSETENYI J; KERPEL FRONIUS S et al.1979; EUROP. J. CANCER; GBR; DA. 1979; VOL. 15; NO 3; PP. 337-344; BIBL. 17 REF.Article

Treatment of advanced adenocarcinoma of the kidney with mitolactol: a Southeastern cancer study group trialBRUBAKER, L. H; OWENS NELSON, M. JR; BIRCH, R et al.Cancer treatment reports. 1986, Vol 70, Num 2, pp 304-306, issn 0361-5960Article

Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancerFALKSON, G; GELMAN, R. S; TORMEY, D. C et al.Cancer treatment reports. 1985, Vol 69, Num 7-8, pp 755-760, issn 0361-5960Article

Salvage therapy in advanced breast cancerPARIDAENS, R. J.European journal of cancer & clinical oncology. 1985, Vol 21, Num 12, pp 1443-1447, issn 0277-5379Article

CHROMATIN PROTEINS AS A POSSIBLE TARGET FOR ANTITUMOUR AGENTS: ALTERATIONS OF CHROMATIN PROTEINS IN DIBROMODULCITOL TREATED YOSHIDA TUMORSJENEY A; DZURILLAY E; LAPIS K et al.1979; CHEMICO-BIOL. INTERACTIONS; NLD; DA. 1979; VOL. 26; NO 3; PP. 349-361; BIBL. 34 REF.Article

  • Page / 3